Źródła:
1. Cadoret A., Ovejero C., Terris B., Souil E., Levy L., Lamers W.H., Kitajewski J., Kahn A., Perret C.: New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene, 2002; 21: 8293–8301
2. Caso G., McNurlan M.A., McMillan N.D., Eremin O., Garlick P.J.: Tumour cell growth in culture: dependence on arginine. Clin. Sci., 2004; 107: 371–379
3. Cederbaum S.D., Yu H., Grody W.W., Kern R.M., Yoo P., Iyer R.K.: Arginases I and II: do their functions overlap? Mol. Genet. Metab., 2004; 81(Suppl.1): S38–S44
4.Flynn N.E., Meininger C.J., Haynes T.E., Wu G.: The metabolic basis of arginine nutrition and pharmacotherapy. Biomed. Pharmacother., 2002; 56: 427–438
5. https://pubmed.ncbi.nlm.nih.gov/8019615/
6. Flynn N.E., Meininger C.J., Haynes T.E., Wu G.: The metabolic basis of arginine nutrition and pharmacotherapy. Biomedicine & Pharmacotherapy., 2002; 56: 427–438.
